|
![]() |
|||
|
||||
OverviewFull Product DetailsAuthor: James Kew (Director, Molecular and Cellular Biology, Schizophrenia & Cognitive Disorders Discovery Performance Unit, Neurosciences CEDD, GlaxoSmithKline, New Frontiers Science Park, Harlow, U.K.) , Ceri Davies (, Mood and Anxiety Doisorders Discovery Performance Unit, Neurosciences CEDD, GlaxoSmithKline, Medicines Research Center, Via A Fleming, Verona, Italy)Publisher: Oxford University Press Imprint: Oxford University Press Dimensions: Width: 22.70cm , Height: 2.80cm , Length: 28.40cm Weight: 1.733kg ISBN: 9780199296750ISBN 10: 0199296758 Pages: 576 Publication Date: 17 September 2009 Audience: College/higher education , Professional and scholarly , Postgraduate, Research & Scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: To order ![]() Stock availability from the supplier is unknown. We will order it for you and ship this item to you once it is received by us. Table of ContentsIntroduction 1: Derek Tresize, Tim Dale and Martin Main: Introduction to Ion Channel Structure and Function Voltage Gated Ion Channels 2.1: Bernardo Rudy: Voltage-Gated K+ channels 2.2: Bernardo Rudy, Jonathon Maffie, Yimy Amarillo, Brian Clark, Hyo-Young Jeong, Illya Kruglikov, Elaine Kwon, Marcela Nadal and Edward Zagha: Kv1-Kv6 \ Kv8-Kv9 family 2.3: Jonathan Robbins and Gayle Passmore: Kv7 family 2.4: Matthew Perry and Michael Sanguinetti: Kv10-Kv12 families 2.5: Dawon Kang and Donghee Kim: K2P families 2.6: Joel Baumgart and Edward Perez-Reyes: Voltage-Gated Ca2+ Channels 2.7: Sulayman Dib-Hajj and Tony Priestley: Voltage-Gated Na+ Channels 2.8: Michael Pusch: Voltage-Gated Chloride Channels 2.9: Mira Kuisle and Anita Lüthi: Hyperpolarization-Activated Channels Extracellular Ligand-Gated Ion Channels 3.1: Cys Loop Receptors 3.2: Marzia Lecchi, Jean-Charles Hoda, Ronald Hogg and Daniel Bertrand: Nicotinic Acetylcholine Receptors 3.3: John Peters, Michelle Cooper, Matthew Livesey, Jane Carland and Jeremy Lambert: 5-HT3 receptors 3.4: Carmen Villmann and Cord-Michael Becker: Glycine Receptors 3.5: Hans Möhler, Dietmar Benke Uwe Rudolph and Jean-Marc Fritschy: GABAA receptors 3.6: Glutamate Receptors 3.7: Laura Jane King, Hilary Jackson, Thomas Chater, Peter Hastie and Jeremy Henley: AMPA Receptors 3.8: Sanja Selak, Rocio Rivera, Ana Paternain and Juan Lerma: Kainate Receptors 3.9: Alasdair Gibb: NMDA Receptors 3.10: ATP Receptors 3.11: Iain Chessell and Anton Michel: P2X Receptors 3.12: Others 3.13: Eric Lingueglia and Michel Lazdunski: Acid Sensing Ion Channels (ASICs) 3.14: Stephan Kellenberger and Laurent Schild: Epithelial Sodium Channels Intracellular Ligand-Gated Ion Channels 4.1: Jorge Arreola, Juan Pablo Reyes, Teresa Rosales-Saavedra and Patricia Pérez-Cornejo: Chloride Channels Activated by Intracellular Ligands 4.2: Zhengchao Wang and Fangxiong Shi: Cyclic Nucleotide-Gated Cation Channels 4.3: Morten Grunnet, Dorte Strøbæk, Søren-Peter Olesen and Palle Christophersen: KCa1- KCa5 Families 4.4: KIR family 4.5: Hiroshi Hibino and Yoshihisa Kurachi: KIR1,2,4,5,7 families 4.6: Atsushi Inanobe and Yoshihisa Kurachi: KIR3 family 4.7: Christophe Moreau, Andre Terzic and Michel Vivaudou: KIR6 (KATP) family 4.8: Stephan Lehnart and Andrew Marks: Ryanodine Receptors 4.9: Randen Patterson: IP3 receptor Polymodal Gated Ion Channels 5.1: Grzegorz Owsianik, Thomas Voets and Bernd Nilius: Transient Receptor Potential Channels 5.2: Elizabeth Hartfield, Annette Weil, James Uney and Eric Southam: Connexins - Gap JunctionsReviewsAuthor InformationJames Kew received a degree in Biological Sciences from Exeter University in 1991 and a Ph.D. from Cambridge University in 1995. He joined F.Hoffmann-La Roche in Basel in 1995, first as a postdoctoral scientist and subsequently as head of an electrophysiology and cell biology laboratory. During this period his work focussed on the pharmacology, physiology/pathophysiology and therapeutic potential of both ionotropic and metabotropic glutamate receptors and their ligands. He joined GlaxoSmithKline in 1995 as Head of Electrophysiology in the Psychiatry CEDD before moving to head the newly formed Psychiatry Discovery Technology Group in October 2006. Since October 2008 he has led the Molecular and Cellular Biology group within the Schizophrenia and Cognitive Disorders Discovery Performance Unit in the Neurosciences CEDD. Ceri Davies received BSc (Hons) and Ph.D. degrees in Pharmacology from Bristol University in 1988 and 1991. He held a Lectureship in Neuropharmacology at the University of Edinburgh until 1998 when he moved into the pharmaceutical industry running an electrophysiology team at Organon laboratories near Glasgow. During this appointment his work focussed on developing novel approaches to treat psychiatric disorders. He joined GlaxoSmithKline a year later as Head of Electrophysiology in the Neurology and Gastrointestinal Centre for Excellence in Drug Discovery (CEDD) before moving to head up the Neuropharmacology and Physiology department in the Psychiatry CEDD in 2003. Since May 2008 he has led the Synaptic Plasticity and Neural Networks Discovery Performance Unit within the newly formed Neurosciences CEDD. Tab Content 6Author Website:Countries AvailableAll regions |